(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. L'...

Full description

Saved in:
Bibliographic Details
Main Authors ORTEGA MUNOZ, ALBERTO, FYFE, MATHEW COLIN THOR, ESTIARTE MARTINEZ, MARIA DE LOS ANGELES, VALLS VIDAL, NURIA, MARTINELL PEDEMONTE, MARC, KURZ, GUIDO, CASTRO PALOMINO LARIA, JULIO CESAR
Format Patent
LanguageEnglish
French
Published 25.04.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula I as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. L'invention concerne des composés (hétéro)aryle cyclopropylamines, comprenant en particulier les composés de formule I tels que décrits et définis présentement, et leur utilisation en thérapie, notamment par exemple dans le traitement ou la prévention du cancer, d'une maladie ou d'un état neurologique ou d'une infection virale.
Bibliography:Application Number: WO2012EP70898